Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fresenius Medical Care AG (FMS) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to 7.2%.

  • Fresenius Medical Care AG's EBITDA Margin rose 300.0% to 9.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.06%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 7.2% for FY2024, which is 1600.0% up from last year.
  • Latest data reveals that Fresenius Medical Care AG reported EBITDA Margin of 7.2% as of FY2024, which was up 1600.0% from 7.04% recorded in FY2023.
  • Over the past 5 years, Fresenius Medical Care AG's EBITDA Margin peaked at 12.9% during FY2020, and registered a low of 7.04% during FY2023.
  • Moreover, its 5-year median value for EBITDA Margin was 7.79% (2022), whereas its average is 9.09%.
  • In the last 5 years, Fresenius Medical Care AG's EBITDA Margin tumbled by -27200bps in 2022 and then surged by 1600bps in 2024.
  • Over the past 5 years, Fresenius Medical Care AG's EBITDA Margin (Annual) stood at 12.9% in 2020, then dropped by -19bps to 10.51% in 2021, then fell by -26bps to 7.79% in 2022, then dropped by -10bps to 7.04% in 2023, then increased by 2bps to 7.2% in 2024.
  • Its last three reported values are 7.2% in FY2024, 7.04% for FY2023, and 7.79% during FY2022.